Pourakbari Babak, Abdolsalehi Mohamadreza, Mahmoudi Shima, Banar Maryam, Masoumpour Farbod, Mamishi Setareh
Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, No.62, Gharib St., Keshavarz Blvd., Tehran, Iran.
Wien Med Wochenschr. 2019 Jun;169(9-10):232-239. doi: 10.1007/s10354-019-0685-z. Epub 2019 Feb 18.
Brucellosis is endemic in Iran. Children constitute 20-25% of cases. We determined clinical, laboratory, and epidemiologic characteristics of pediatric brucellosis patients hospitalized at the Children's Medical Center from May 2011 to December 2016.
Medical records were reviewed retrospectively. For each patient, a questionnaire was provided containing demographic characteristics (sex, age, nationality, date of admission, city of residence, history of ingestion of unpasteurized dairy products, family history of brucellosis, history of contact with suspicious animals) and clinical information (signs and symptoms, laboratory findings, history of disease relapse, treatment).
Included were 43 patients diagnosed with brucellosis (26 males, 60.5%; age 1-13 years, mean ± SD: 7.02 ± 3.5). A history of ingestion of raw or unpasteurized dairy products was present in 88% (N = 38) and 11 patients (26%) had had contact with a suspicious animal. Highest frequencies of brucellosis were recorded in 2013 (N = 10, 23%) and 2015 (N = 11, 26%). Most cases were admitted in the summer (N = 14, 33%) and spring (N = 12, 28%). Fever (N = 39, 91%), arthralgia (N = 33, 77%), and malaise (N = 33, 77%) were the main complaints. Anemia (65%), lymphocytosis (51%), and elevated erythrocyte sedimentation rate (86%) and C‑reactive protein (67%) were the most prominent blood anomalies. Blood culture was positive in 30% (N = 11/37), bone marrow culture in 31% (N = 4/11). A positive Wright, Coombs Wright, and 2 ME test was observed in 67% (N = 29), 92% (N = 34/37), and 85% (N = 34/40) of cases, respectively. Median length of antibiotic therapy was 12 weeks (2-24 weeks). The most frequent drug regimen was combined trimethoprim-sulfamethoxazole and rifampicin (N = 24, 56%). Relapse occurred in 9 patients (21%), there were no deaths.
Physicians should be aware of the manifestations, diagnosis, and treatment protocols of childhood brucellosis. Control programs and preventive measures, e.g., regular examination of domestic animals, mass vaccination of livestock, slaughter of infected animals, control of animal trade and migration, pasteurization of milk and milk products, training and increased public awareness of the dangers of consumption of unpasteurized dairy products, are highly recommended.
布鲁氏菌病在伊朗呈地方性流行。儿童病例占20% - 25%。我们确定了2011年5月至2016年12月在儿童医学中心住院的小儿布鲁氏菌病患者的临床、实验室和流行病学特征。
对病历进行回顾性审查。为每位患者提供一份问卷,内容包括人口统计学特征(性别、年龄、国籍、入院日期、居住城市、食用未杀菌乳制品史、布鲁氏菌病家族史、接触可疑动物史)和临床信息(体征和症状、实验室检查结果、疾病复发史、治疗情况)。
纳入43例诊断为布鲁氏菌病的患者(26例男性,占60.5%;年龄1 - 13岁,平均±标准差:7.02±3.5)。88%(N = 38)的患者有食用生的或未杀菌乳制品的病史,11例患者(26%)接触过可疑动物。2013年布鲁氏菌病发病率最高(N = 10,23%),2015年次之(N = 11,26%)。大多数病例在夏季(N = 14,33%)和春季(N = 12,28%)入院。主要症状为发热(N = 39,91%)、关节痛(N = 33,77%)和全身不适(N = 33, 77%)。最突出的血液异常表现为贫血(65%)、淋巴细胞增多(51%)、红细胞沉降率升高(86%)和C反应蛋白升高(67%)。血培养阳性率为30%(N = 11/37),骨髓培养阳性率为31%(N = 4/11)。Wright试验、Coombs Wright试验和2ME试验阳性率分别为67%(N = 29)、92%(N = 34/37)和85%(N = 34/40)。抗生素治疗的中位时长为12周(2 - 24周)。最常用的药物方案是复方磺胺甲恶唑和利福平联合使用(N = 24,56%)。9例患者(21%)复发,无死亡病例。
医生应了解儿童布鲁氏菌病的表现、诊断和治疗方案。强烈建议实施控制计划和预防措施,如定期检查家畜、对牲畜进行大规模疫苗接种、屠宰感染动物、控制动物贸易和迁移、对牛奶和奶制品进行巴氏杀菌、培训并提高公众对食用未杀菌乳制品危害的认识。